Literature DB >> 12070297

Optimizing hematopoietic recovery following bone marrow transplantation.

Ronald Paquette1, Kenneth Dorshkind.   

Abstract

Mesh：

Year:  2002        PMID： 12070297      PMCID： PMC151019          DOI： 10.1172/JCI15916

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells.

Authors:  J Reiffers; C Cailliot; B Dazey; M Attal; J Caraux; J M Boiron
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

2.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

3.  The genetic program of hematopoietic stem cells.

Authors:  R L Phillips; R E Ernst; B Brunk; N Ivanova; M A Mahan; J K Deanehan; K A Moore; G C Overton; I R Lemischka
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

4.  Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer.

Authors:  R L Paquette; S T Dergham; E Karpf; H J Wang; D J Slamon; L Souza; J A Glaspy
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

5.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S.

Authors:  Thanyaphong Na Nakorn; David Traver; Irving L Weissman; Koichi Akashi
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 6.  Introduction to the haemopoietic system.

Authors:  T M Dexter
Journal:  Cancer Surv       Date:  1990

7.  Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.

Authors:  I McNiece; R Jones; S I Bearman; P Cagnoni; Y Nieto; W Franklin; J Ryder; A Steele; J Stoltz; P Russell; J McDermitt; C Hogan; J Murphy; E J Shpall
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

8.  Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery.

Authors:  Ronald L Paquette; Sanaa T Dergham; Ellen Karpf; He-Jing Wang; Dennis J Slamon; Larry Souza; John A Glaspy
Journal:  Exp Hematol       Date:  2002-04       Impact factor: 3.084

9.  Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.

Authors:  Heeje Kim; Katharine A Whartenby; Robert W Georgantas; John Wingard; Curt I Civin
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

10.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728
View more
  2 in total

Review 1.  Stem cell myths.

Authors:  Tim Magnus; Ying Liu; Graham C Parker; Mahendra S Rao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

2.  Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO.

Authors:  Olga Tura; G Robin Barclay; Huw Roddie; John Davies; Marc L Turner
Journal:  J Transl Med       Date:  2007-10-30       Impact factor: 5.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.